Imerys (NK) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
31 Oct, 2026Executive summary
FY2023 revenue was €3,794m, down 9.0% like-for-like; current EBITDA was €633m, within €630m–€650m guidance, with a 16.7% margin.
Net current free operating cash flow rose to €191m from €20m; net financial debt fell €548m, or 33%, to €1,118m.
Current net income from continuing operations was €242m; reported net income was €51m, including €44m from discontinued activities.
Financial highlights
Revenue was €3,794m versus €4,282m in 2022; reported change was -11.4%, with a negative €83m currency effect and negative €31m scope effect.
Volumes reduced revenue by €483m; price-mix contributed €109m, or 2.6%, while Q4 pricing was -4.4% against a high comparison and after energy and freight surcharges ended.
Current EBITDA was €633m versus €720m; margin was 16.7% versus 16.8%. Cost-saving actions delivered €126m, more than offsetting 2.8% inflation.
Current operating income was €365m versus €439m; current net income from continuing operations was €242m, down 12.8%, and current EPS was €2.86 versus €3.28.
Net current free operating cash flow was €191m after capex and right-of-use assets; before strategic capex it was €288m versus €105m in 2022.
Outlook and guidance
FY2023 current EBITDA of €633m met July guidance of €630m–€650m.
After unprecedented 2023 destocking, markets stabilized; construction, especially residential, and automotive were expected to remain weak, while consumer, life sciences, energy and electronics were expected to progress.
Priorities included strict cost discipline and growth through new capacity, innovation, mobile and sustainable energy exposure, and continued GHG reduction.
Latest events from Imerys
- 9M adjusted EBITDA rose 10.3%; FY guidance increased to €570m–€590m.NK
Q3 2026 - H1 2026 saw 1.8% revenue and 10% EBITDA growth, margin gains, and strong cash flow.NK
Q2 2026 - Stable results, €0.75 dividend, strategic focus on lithium, cost savings, and strong ESG progress.NK
AGM 2026 - Q1 2026 saw modest growth and margin gains, offset by FX and restructuring impacts.NK
Q1 2026 - Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 2025 - Nine-month revenue fell 0.7% to €2,583m; EBITDA guidance and cost actions reaffirmed.NK
Q3 2025 - H1 2024 adjusted EBITDA up 11% to €384m, margin 20%, and net income from continuing ops up 25%.NK
H1 2024 - All resolutions passed, with strong 2024 results, higher dividend, and strategic progress.NK
AGM 2025 - Solid organic growth, margin expansion, and strong ESG progress despite non-cash net loss.NK
H2 2024